Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Safety and Efficacy of Nonacog Beta Pegol (N9-GP) in Previously Untreated Patients With Haemophilia B (paradigm™6)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02141074
Recruitment Status : Active, not recruiting
First Posted : May 19, 2014
Last Update Posted : December 1, 2021
Information provided by (Responsible Party):
Novo Nordisk A/S